{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:35:06Z","timestamp":1794620106982,"version":"4.9.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1093\/rheumatology\/ket152","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T21:01:15Z","timestamp":1366923675000},"page":"1467-1476","source":"Crossref","is-referenced-by-count":86,"title":["A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8\/14 protein"],"prefix":"10.1093","volume":"52","author":[{"given":"Halima","family":"Moncrieffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ursu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Holzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kassoumeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"key\n\t\t\t\t20170522170257_ket152-B1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.10863","article-title":"Outcome in adults with juvenile idiopathic arthritis: a quality of life study","volume":"48","author":"Foster","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B2","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.30426","article-title":"Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis","volume":"63","author":"Nordal","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","article-title":"Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO","volume":"51","author":"Minden","year":"2012","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522170257_ket152-B4","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","article-title":"Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis","volume":"60","author":"Giannini","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/acr.20283","article-title":"Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t20170522170257_ket152-B7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522170257_ket152-B8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t20170522170257_ket152-B9","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B10","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522170257_ket152-B11","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1371\/journal.pmed.0050172","article-title":"Children are not just small adults: the urgent need for high-quality trial evidence in children","volume":"5","author":"Klassen","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170522170257_ket152-B12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.24087","article-title":"Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis","volume":"61","author":"Albers","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/ard.2007.073445","article-title":"The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis","volume":"67","author":"Bartoli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FPC.0b013e32833f2cd0","article-title":"Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype","volume":"20","author":"Moncrieffe","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"key\n\t\t\t\t20170522170257_ket152-B15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2010.146191","article-title":"Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis","volume":"70","author":"Hinks","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B16","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/art.25008","article-title":"Do mothers and fathers hold similar views about their child's arthritis?","volume":"61","author":"Mulligan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522170257_ket152-B18","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1136\/annrheumdis-2012-201329","article-title":"Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study","volume":"71","author":"Gerss","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B20","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522170257_ket152-B21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B22","first-page":"S163","article-title":"The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)","volume":"19","author":"Nugent","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t20170522170257_ket152-B23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","article-title":"Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis","volume":"43","author":"Frosch","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","article-title":"The Toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis","volume":"71","author":"Holzinger","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/ard.62.3.236","article-title":"Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation","volume":"62","author":"Wulffraat","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"de Jager","year":"2009","journal-title":"BMC Immunol"},{"key":"key\n\t\t\t\t20170522170257_ket152-B29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.2008.170019","article-title":"Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage","volume":"58","author":"Foell","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170522170257_ket152-B30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11926-010-0085-2","article-title":"Remission in juvenile idiopathic arthritis: current facts","volume":"12","author":"Shenoi","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t20170522170257_ket152-B31","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/annrheumdis-2011-200942","article-title":"Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis","volume":"71","author":"Bulatovic","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170257_ket152-B32","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/art.22640","article-title":"A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis","volume":"56","author":"Wessels","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170257_ket152-B33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2217\/pgs.12.83","article-title":"Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure","volume":"13","author":"Fransen","year":"2012","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20170522170257_ket152-B34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/s10165-009-0187-8","article-title":"Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population","volume":"19","author":"Iwamoto","year":"2009","journal-title":"Mod Rheumatol"},{"key":"key\n\t\t\t\t20170522170257_ket152-B35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/rheumatology\/kep352","article-title":"Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study","volume":"49","author":"Hyrich","year":"2010","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522170257_ket152-B36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","article-title":"Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO","volume":"51","author":"Minden","year":"2012","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/52\/8\/1467\/17388147\/ket152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T10:08:37Z","timestamp":1715249317000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/ket152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,4,25]]},"published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ket152","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}